For Members
Statements and Testimony - 2002
- November 11, 2002 - NCCI Version 9.1 CPT Coding Edits
ASM provided comments to the Centers for Medicare and Medicaid Services (CMS) federal contractor, AdminaStar Federal, regarding the National Corrective Coding Initiative (NCCI) version 9.1 edits.
- November 8, 2002 - Research and Public Health Programs Appropriations for FY 2003
The ASM sent a letter to all members of Congress urging action on FY 2003 Appropriations for the Department of Health and Human Services, research and public health programs.
-
On October 10, 2002 - ASM Testimony: Conducting Research During the War on Terrorism: Balancing Openness and Security
Dr. Ronald Atlas, President of ASM testified before the House Committee on Science at a hearing on "Conducting Research During the War on Terrorism: Balancing Openness and Security."
- October 7, 2002 - Payment Determinations Recommended by CMS for the 2003 Laboratory Fee Schedule
ASM sent comments to the Centers for Medicare and Medicaid Services (CMS) in response to the tentative payment determinations recommended by CMS for the 2003 laboratory fee schedule.
- September 24, 2002 - Letter to Senator Phil Gramm (R-TX) Regarding Homeland Security
ASM Urges Adoption of House Provisions for Biodefense Research and Public Health in Senate Version of Homeland Security Bill.
- September 10, 2002 - NSF FY 2003 Funding for the Biological Sciences Directorate
ASM sent a letter to the House Appropriations Subcommittee on VA/HUD/Independent Agencies on the National Science Foundation Biological Sciences Directorate's FY 2003 Budget
- August 23, 2002 - ASM Recommendations on Biodefense Research Funded by the National Institute of Allergy and Infectious Diseases
ASM Sent a letter to the House Appropriations Subcommittee on Labor, Health and Human Services and Related Agencies Biodefense Research Supported by the NIAID.
- August 7, 2002 - Payment Determinations for Calendar Year 2003 for New Clinical Laboratory Tests
The Professional Affairs Committee Member, Vickie Baselski, presented comments before the Centers for Medicare and Medicaid Services (CMS) at its public meeting regarding payment methodology for new Current Procedural Terminology (CPT) codes which will be used in the 2003 Medicare Clinical Laboratory Fee Schedule.
- July 30, 2002 - Letter to Senator Joseph Lieberman (D-CT) Regarding Homeland Security Amendment
ASM Outlines Concerns Raised by Biodefense Research Amendment to the National Homeland Security and Combating Terrorism Act of 2002, S. 2452.
- July 23, 2002 - ASM Submits Points to Consider and Recommendations to the Centers for Disease Control and Prevention Regarding Select Agents and Toxins
ASM submitted points to consider and recommendations for implementation of Title II, Enhancing Controls and Dangerous Biological Agents and Toxins to the Centers for Disease Control and Prevention.
- July 16, 2002 - Draft Guidance for Industry: Premarket Notifications [510(k)s] for In Vitro HIV Drug Resistance Genotype Assays: Special Controls."
ASM's Laboratory Practices Committee submitted comments to the Food and Drug Administration (FDA) on its draft guidance document, "Guidance for Industry: Premarket Notifications [510(k)s] for In Vitro HIV Drug Resistance Genotype Assays: Special Controls."
- July 16, 2002 - FDA on its Draft Guidance Document, "Guidance for Industry: Use of Nucleic Acid Tests"
ASM's Laboratory Practices Committee submitted comments to the Food and Drug Administration regarding its draft guidance document, "Guidance for Industry: Use of Nucleic Acid Tests on Pooled and Individual Samples from Donors of Whole Blood and Blood Components for Transfusion to Adequately and Appropriately Reduce the Risk of Transmission of HIV-1 and HCV," published in the Federal Register on April 9, 2002.
- July 16, 2002 - Letter to Representative Richard Armey on the Creation of the Department of Homeland Security
ASM sent a letter to Represenative Armey (R-TX) endorsing the recommendations and provisions of the House Energy and Commerce Committee Proposal on Homeland Security Legislation.
- July 12, 2002 - ASM Endorses House Energy and Commerce Committee Proposal on Homeland Security Legislation
ASM sent a letter to Representative W. J. "Billy" Tauzin (R-LA) to commend the bipartisan recommendations and provisions of the House Energy and Commerce Committee for the Department of Health and Human Services (DHHS) in HR 5005, which establishes the Department of Homeland Security (DHS).
- July 11, 2002 - NCCI Version 8.3 CPT Coding Edits
ASM provided comments to the Centers for Medicare and Medicaid Services (CMS) federal contractor, AdminaStar Federal, regarding the National Corrective Coding Initiative (NCCI) version 8.3 edits.
- July 11, 2002 - Smallpox Vaccination Recommendations
ASM sent comments to Dr. Julie Gerberding, Director of the Centers for Disease Control and Prevention on recommendations for the smallpox vaccination.
- July 11, 2002 - Possession of a Select Agent
ASM submitted comments to the Centers for Disease Control and Prevention on the July 2, Federal Register notice on proposed data collections for notification of possession of a select agent.
- July 9, 2002 - ASM Testimony on the Department of Homeland Security
Dr. Gail Cassell, Chair of the Public and Scientific Affairs Board presented testimony on the establishment on the Department of Homeland Security.
- June 25, 2002 - ASM Testimony on the Department of Homeland Security
Dr. Ronald Atlas, President of the American Society for Microbiology presented testimony before the House Energy and Commerce Subcommittee on Oversight and Investigations at a hearing to consider the creation of the Department of Homeland Security (DHS)."
- June 19, 2002 - Preservation of Antibiotics for Human Treatment Act of 2002
On June 15, 2002 ASM sent comments to Representative Sherrod Brown (D-OH) regarding the Preservation of Antibiotics for Human Treatment Act of 2002.
- June 17, 2002 - Draft Guideline for Disinfection and Sterilization in Healthcare Facilities
The ASM submitted comments to the Centers for Disease Control and Prevention on the Draft Guideline for Sterlization and Disinfection in Healthcare Facilities. The guideline, which was published in the April 30 Federal Register, is intended to replace the section in Guideline for Handwashing and Hospital Environmental Control, 1985, that dealt with sterilization and disinfection.
- June 12, 2002 - Establishing the Department of Homeland Security
ASM sent comments to Congress regarding the President's proposal to establish the Department of Homeland Security.
- May 9, 2002 - Office of Technology Assessment
The ASM sent a letter to Representative Rush Holt (D-NJ) supporting the bill H.R. 2148 which would reestablish the Office of Technology Assessment (OTA).
- May 1, 2002 - Use of Nucleic Acid Tests on Pooled Samples From Source Plasma Donors to Adequately and Appropriately Reduce the Risk of Transmission of HIV-1 and HCV
On April 30, ASM's Laboratory Practices Committee submitted comments to the Food and Drug Administration regarding its draft guidance for industry, "Use of Nucleic Acid Tests on Pooled Samples From Source Plasma Donors to Adequately and Appropriately Reduce the Risk of Transmission of HIV-1 and HCV, " published in the Federal Register on January 31, 2002.
- April 3, 2002 - FDA Guidance Document on the the Effects of Antimicrobial Drug Residues From Food of Animal Origin on the Human Intestinal Flora
On March 27, the ASM's Committee on Agriculture and Food Microbiology submitted comments to the Food and Drug Administration in response to the agency's draft guidance for industry, "Assessment of the Effects of Antimicrobial Drug Residues From Food of Animal Origin on the Human Intestinal Flora," published December 27, 2001, in the Federal Register.
- April 1, 2002 - National Institutes of Health - FY 2003 Testimony
Appropriations statement regarding NIH funding for FY 2003.
- April 1, 2002 - Centers for Disease Control and Prevention - FY 2003 Testimony
Appropriations statement regarding CDC funding for FY 2003.
- April 1, 2002 - National Science Foundation - FY 2003 Testimony
Appropriations statement regarding NSF funding for FY 2003.
- April 1, 2002 - Food and Drug Administration - FY 2003 Testimony
Appropriations statement regarding FDA funding for FY 2003.
- April 1, 2002 - U.S. Department of Agriculture - FY 2003 Testimony
Appropriations statement regarding USDA funding for FY 2003.
- April 1, 2002 - Environmental Protection Agency - FY 2003 Testimony
Appropriations statement regarding EPA funding for FY 2003.
- April 1, 2002 - Department of Energy - FY 2003 Testimony
Appropriations statement regarding DOE funding for FY 2003.
- April 1, 2002 - U.S. Geological Survey (USGS) - FY 2003 Testimony
Appropriations statement regarding USGS funding for FY 2003.
- February 4, 2002 - ASM Commends the President's Budget Request for the National Institutes of Health
- January 28, 2002 - ASM Comments on Qualification Requirements for Directors of Laboratories Performing High Complexity Testing
The ASM submitted comments to the Centers for Disease Control and Prevention (CDC) and the Centers for Medicare and Medicaid Services (CMS) regarding a proposed rule on Medicare, Medicaid and CLIA Programs: Qualification Requirements for Directors of Laboratories Performing High Complexity Testing, published in the Federal Register on December 28, 2001.
- January 7, 2002 - ASM Comments on Draft Risk Assessment for Escherichia coli (E. coli) O157:H7 in Ground Beef
The ASM's Committee on Agriculture and Food Microbiology submitted comments to the Food Safety and Inspection Service in response to the agency's draft Risk Assessment for Escherichia coli (E. coli) O157:H7 in ground beef, published November 5, 2001, in the Federal Register.